Korro Bio, Inc. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
Korro Bio, Inc. (KRRO) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $151.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-11-16
- 2020-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $151.00K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $302.00K.
- 2020-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $426.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2020-09-30 | $151.00K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $302.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $426.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |